AU4387799A - Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds - Google Patents

Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds

Info

Publication number
AU4387799A
AU4387799A AU43877/99A AU4387799A AU4387799A AU 4387799 A AU4387799 A AU 4387799A AU 43877/99 A AU43877/99 A AU 43877/99A AU 4387799 A AU4387799 A AU 4387799A AU 4387799 A AU4387799 A AU 4387799A
Authority
AU
Australia
Prior art keywords
intermediates
synthesis
active compounds
building blocks
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43877/99A
Inventor
Gesine Hermann
Christian Kocher
Trevor Murphy
Angelo Nikolopoulos
Helmut Schickaneder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Russinsky Ltd
Original Assignee
Russinsky Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Russinsky Ltd filed Critical Russinsky Ltd
Publication of AU4387799A publication Critical patent/AU4387799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/003Compounds containing elements of Groups 2 or 12 of the Periodic System without C-Metal linkages
AU43877/99A 1998-06-26 1999-06-18 Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds Abandoned AU4387799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE980514 1998-06-26
IE980514 1998-06-26
PCT/IE1999/000055 WO2000000474A1 (en) 1998-06-26 1999-06-18 Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
AU4387799A true AU4387799A (en) 2000-01-17

Family

ID=11041834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43877/99A Abandoned AU4387799A (en) 1998-06-26 1999-06-18 Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds

Country Status (3)

Country Link
AU (1) AU4387799A (en)
IE (1) IE990506A1 (en)
WO (1) WO2000000474A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104817492B (en) * 2015-05-22 2018-05-18 抚州三和医药化工有限公司 Lansoprazole intermediate 2- methylol -3- methyl -4- (2,2,2- trifluoro ethoxies)The isolation and purification method of pyridine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (en) * 1978-04-14 1979-10-15 Haessle Ab Gastric acid secretion
SE8204879D0 (en) * 1982-08-26 1982-08-26 Haessle Ab NOVEL CHEMICAL INTERMEDIATES
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (en) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd Pyridine derivative and preparation thereof
JPH0643426B2 (en) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 Imidazo [4,5-b] pyridine derivative, method for producing the same, and antiulcer agent containing the same
FI90544C (en) * 1986-11-13 1994-02-25 Eisai Co Ltd Process for Preparation as Drug Useful 2-Pyridin-2-yl-methylthio- and sulfinyl-1H-benzimidazole derivatives
JP3029901B2 (en) * 1991-08-28 2000-04-10 三菱東京製薬株式会社 Method for producing 2-hydroxymethyl-4-methoxy-3,5-dimethylpyridine by a novel methoxy group introduction method

Also Published As

Publication number Publication date
WO2000000474A1 (en) 2000-01-06
IE990506A1 (en) 2000-11-15

Similar Documents

Publication Publication Date Title
EP1180015B8 (en) Generation of therapeutic microfoam
AU2184100A (en) Building structures
AU3181099A (en) Storage-stable compositions useful for the production of structural foams
AU2557500A (en) Methods of making compounds
AU4150200A (en) Steel-frame structure and method of construction by using the same
AU7022098A (en) Synthesis of pharmaceutically useful pyridine derivatives
AU5587200A (en) Synthesis of substituted amidines
AU4416300A (en) Ceiling slab
AU1651001A (en) Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
EP1001962B8 (en) Production of avermectin compounds
AU5433699A (en) Spacing of tiles
AU6769900A (en) Formation of nanometer-scale structures
AU5086100A (en) Improvements relating to the formation of uniform blocks of foodstuff
AU3921000A (en) Building construction
AU3904499A (en) Production of foamed compositions containing gypsum
AUPO459997A0 (en) Improved building structures
AU4387799A (en) Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
AU5998299A (en) Intermediates in the production of oxime ether compounds
AU7711800A (en) Novel uses of 2-bromopalmitate
AU6210198A (en) Play building blocks
AU2088000A (en) Surveillance of structures
AU1695901A (en) Process for the preparation of intermediates useful in the synthesis of diarylpyridines
AU1656699A (en) Synthesis of pharmaceutically useful pyridine derivatives
AU3292700A (en) Improvements to the construction of video games
AU2000233198A1 (en) Method for the continuous production of foam panels

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase